CLBT Logo.png
Cellebrite and The Exodus Road Continue Combatting Human Trafficking in Brazil
January 30, 2023 07:00 ET | Cellebrite DI Ltd
PETAH TIKVA, Israel and TYSONS CORNER, Va. and COLORADO SPRINGS, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions...
ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Preliminary Financial Results for Fiscal Year 2022
January 30, 2023 07:00 ET | ACM Research, Inc.
FREMONT, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ACM Research, Inc. (ACM) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging...
Descartes Systems Group Logo
Descartes’ Study Reveals 65% of Companies Plan to Accelerate Supply Chain and Logistics Innovation Investment
January 30, 2023 06:45 ET | The Descartes Systems Group Inc.
ATLANTA and LONDON, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, released findings...
daseke-logo with (R) as of Aug 2015.jpg
Daseke Names Adrianne D. Griffin Vice President, Investor Relations and Treasurer
January 30, 2023 06:30 ET | Daseke, Inc.
ADDISON, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), a premier North American transportation solutions specialist dedicated to servicing...
G Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensors
January 30, 2023 06:15 ET | G Medical Innovations Holdings Ltd.
Rehovot, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that it has received a patent issue...
Opthea To Present at Sequire Biotechnology Conference
January 30, 2023 06:00 ET | Opthea Limited
MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
COGI logo 2019.jpg
Coda Octopus Group Reports Fiscal 2022 Financial Results
January 30, 2023 06:00 ET | Coda Octopus Group, Inc.
ORLANDO, FL, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (CODA) (Nasdaq: CODA) today reported its audited financial results for its fiscal year ended October 31, 2022. Annmarie...
Grab to Announce Fourth Quarter and Full Year 2022 Results on February 23, 2023
January 30, 2023 06:00 ET | Grab Holdings Limited
NEW YORK, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Grab Holdings Limited (NASDAQ: GRAB, the “Company” or “Grab”), plans to announce its unaudited fourth quarter and full year 2022 results before the U.S....
Figure 1
Vera Therapeutics Releases 36 Week Interim Analysis of Phase 2b Clinical Trial of Atacicept for the Treatment of IgA Nephropathy; Patients in the 150 mg Dose Group Achieved a Delta of 48% Versus Placebo in Mean Reduction in Proteinuria
January 30, 2023 06:00 ET | Vera Therapeutics
Vera continuing plans to rapidly advance atacicept into a pivotal Phase 3 trial in 1H 2023; full data to be presented at upcoming medical congresses Company plans to prioritize and focus current...
Logo FF-01.jpg
Fusion Fuel Signs Offtake Agreement with Portuguese Gas Utility Dourogás
January 30, 2023 04:00 ET | Fusion Fuel Green Public Limited Company
SABUGO, Portugal, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel (NASDAQ: HTOO) announced today that the company has signed an offtake agreement with Portuguese natural gas utility Dourogás for green...